111 related articles for article (PubMed ID: 26600055)
1. Single Nucleotide Polymorphism of Interleukin-18 and Interleukin-18 Receptor and the Risk of Papillary Thyroid Cancer.
Chung JH; Lee YC; Eun YG; Chung JH; Kim SK; Chon S; Oh SJ; Rhee SY; Hong IK
Exp Clin Endocrinol Diabetes; 2015 Nov; 123(10):598-603. PubMed ID: 26600055
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-1 beta polymorphisms are associated with lymph node metastasis in Korean patients with papillary thyroid carcinoma.
Ban JY; Kim MK; Park SW; Kwon KH
Immunol Invest; 2012; 41(8):888-905. PubMed ID: 23215728
[TBL] [Abstract][Full Text] [Related]
3. Single nucleotide polymorphisms of the Fas gene are associated with papillary thyroid cancer.
Eun YG; Lee YC; Kim SK; Chung JH; Kwon KH; Park IS
Auris Nasus Larynx; 2015 Aug; 42(4):326-31. PubMed ID: 25824544
[TBL] [Abstract][Full Text] [Related]
4. Associations between promoter polymorphism -106A/G of interleukin-11 receptor alpha and papillary thyroid cancer in Korean population.
Eun YG; Shin IH; Kim MJ; Chung JH; Song JY; Kwon KH
Surgery; 2012 Feb; 151(2):323-9. PubMed ID: 21982075
[TBL] [Abstract][Full Text] [Related]
5. Missense polymorphisms in XIAP-associated factor-1 (XAF1) and risk of papillary thyroid cancer: correlation with clinicopathological features.
Kim SK; Park HJ; Seok H; Jeon HS; Kim JW; Chung JH; Kwon KH; Woo SH; Lee BW; Baik HH
Anticancer Res; 2013 May; 33(5):2205-10. PubMed ID: 23645777
[TBL] [Abstract][Full Text] [Related]
6. A gene-disease association study of IL18 in thyroid cancer: genotype and haplotype analyses.
Abdolahi F; Dabbaghmanesh MH; Haghshenas MR; Ghaderi A; Erfani N
Endocrine; 2015 Dec; 50(3):698-707. PubMed ID: 26041375
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-10-1082 gene polymorphism is associated with papillary thyroid cancer.
Çil E; Kumral A; Kanmaz-Özer M; Vural P; Doğru-Abbasoğlu S; Altuntaş Y; Uysal M
Mol Biol Rep; 2014 May; 41(5):3091-7. PubMed ID: 24464184
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms in selected DNA repair genes and cell cycle regulating genes involved in the risk of papillary thyroid carcinoma.
Halkova T; Dvorakova S; Sykorova V; Vaclavikova E; Vcelak J; Vlcek P; Sykorova P; Kodetova D; Betka J; Lastuvka P; Bavor P; Hoch J; Katra R; Bendlova B
Cancer Biomark; 2016 Jun; 17(1):97-106. PubMed ID: 27314298
[TBL] [Abstract][Full Text] [Related]
9. Association between a promoter polymorphism (rs2192752, -1028A/C) of interleukin 1 receptor, type I (IL1R1) and location of papillary thyroid carcinoma in a Korean population.
Park SW; Kim MK; Kwon KH; Kim J
Int J Immunogenet; 2012 Dec; 39(6):501-7. PubMed ID: 22594576
[TBL] [Abstract][Full Text] [Related]
10. Association of Toll-like receptor 2 polymorphisms with papillary thyroid cancer and clinicopathologic features in a Korean population.
Kim MK; Park SW; Kim SK; Park HJ; Eun YG; Kwon KH; Kim J
J Korean Med Sci; 2012 Nov; 27(11):1333-8. PubMed ID: 23166414
[TBL] [Abstract][Full Text] [Related]
11. Association between IL-27 gene polymorphisms and risk of papillary thyroid carcinoma.
Nie X; Yuan F; Chen P; Pu Y; Zhu J; Wang Y; Xiao X; Che G; Gao L; Zhang L
Biomark Med; 2017 Feb; 11(2):141-149. PubMed ID: 27929666
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-10 gene polymorphism in patients with papillary thyroid cancer in Turkish population.
Erdogan M; Karadeniz M; Ozbek M; Ozgen AG; Berdeli A
J Endocrinol Invest; 2008 Sep; 31(9):750-4. PubMed ID: 18997484
[TBL] [Abstract][Full Text] [Related]
13. [Expression of microRNA-221 and IL-17 in papillary thyroid carcinoma and correlation with clinicopathologic features].
Jiang XL; Zhang H; Chen YL; Peng L
Zhonghua Bing Li Xue Za Zhi; 2017 Mar; 46(3):160-165. PubMed ID: 28297755
[No Abstract] [Full Text] [Related]
14. Clinical significance of papillary thyroid cancer risk loci identified by genome-wide association studies.
Wei WJ; Lu ZW; Wang Y; Zhu YX; Wang YL; Ji QH
Cancer Genet; 2015 Mar; 208(3):68-75. PubMed ID: 25746573
[TBL] [Abstract][Full Text] [Related]
15. Association between interleukin 17/interleukin 17 receptor gene polymorphisms and papillary thyroid cancer in Korean population.
Lee YC; Chung JH; Kim SK; Rhee SY; Chon S; Oh SJ; Hong IK; Eun YG
Cytokine; 2015 Feb; 71(2):283-8. PubMed ID: 25484349
[TBL] [Abstract][Full Text] [Related]
16. Association between single nucleotide polymorphisms of upstream transcription factor 1 (USF1) and susceptibility to papillary thyroid cancer.
Yuan Q; Bu Q; Li G; Zhang J; Cui T; Zhu R; Mu D
Clin Endocrinol (Oxf); 2016 Apr; 84(4):564-70. PubMed ID: 26052935
[TBL] [Abstract][Full Text] [Related]
17. Common single nucleotide polymorphisms in genes related to immune function and risk of papillary thyroid cancer.
Brenner AV; Neta G; Sturgis EM; Pfeiffer RM; Hutchinson A; Yeager M; Xu L; Zhou C; Wheeler W; Tucker MA; Chanock SJ; Sigurdson AJ
PLoS One; 2013; 8(3):e57243. PubMed ID: 23520464
[TBL] [Abstract][Full Text] [Related]
18. Correlation among the BRAF gene mutation status, clinicopathological features of primary tumour, and lymph node metastasizing of papillary thyroid carcinoma.
Lukas J; Drabek J; Dudesek B; Vazan P; Stranska J; Jancik S; Mackova M; Syrucek M; Lukas D; Duskova J; Dundr P; Hintnausova B; Jiskra J
Exp Clin Endocrinol Diabetes; 2014 May; 122(5):268-72. PubMed ID: 24839220
[TBL] [Abstract][Full Text] [Related]
19. Interleukin 22 polymorphisms and papillary thyroid cancer.
Eun YG; Shin IH; Lee YC; Shin SY; Kim SK; Chung JH; Kwon KH
J Endocrinol Invest; 2013 Sep; 36(8):584-7. PubMed ID: 23448944
[TBL] [Abstract][Full Text] [Related]
20. MMP-9-1562 C/T single nucleotide polymorphism associates with increased MMP-9 level and activity during papillary thyroid carcinoma progression.
Roncevic J; Djoric I; Selemetjev S; Jankovic J; Dencic TI; Bozic V; Cvejic D
Pathology; 2019 Jan; 51(1):55-61. PubMed ID: 30497805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
